FDA head says working with India to improve drug quality, safety
Feb 18 2014 , Mumbai
Hamburg also urged Indian regulators to work closely with their foreign peers.
Hamburg was speaking to reporters at the end of a visit to India which follows FDA decisions to ban the shipment of drugs to the United States from plants of leading Indian drugmakers including Ranbaxy Laboratories Ltd and Wockhardt Ltd .
During a visit that started on February 10, Hamburg met the Indian drugs regulator and health ministry officials as well as executives of local drugmakers.